Adam Davidson, CEO of Trident Royalties, discusses offtake milestones and catalysts to boost FY24. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHikma Pharmaceuticals Share News (HIK)

Share Price Information for Hikma Pharmaceuticals (HIK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,956.00
Bid: 1,964.00
Ask: 1,966.00
Change: -4.00 (-0.20%)
Spread: 2.00 (0.102%)
Open: 1,994.00
High: 2,000.00
Low: 1,956.00
Prev. Close: 1,960.00
HIK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UPDATE 2-UK shares briefly slip into correction as coronavirus wreaks havoc

Thu, 27th Feb 2020 09:23

* FTSE 100 down 3.5%, FTSE 250 slides 4.1%

* Both indexes briefly in correction

* StanChart slips after warning on virus hit

* WPP slides as Q4 disappoints

* Hikma outshines on bright forecast
(Writes through)

By Sagarika Jaisinghani, Devik Jain and Shashwat Awasthi

Feb 27 (Reuters) - London stocks plummeted on Thursday, with
both benchmark indexes briefly confirming a correction, as a
sharp rise in the number of coronavirus cases outside China
raised fears of a global pandemic and crippled risk appetite.

The FTSE 100 tumbled 3.5% to its lowest since
January 2019, with heavyweight banks, miners and oil stocks
dragging the most. At its lowest in the session, the index was
more than 10% below its peak from just a week ago.

The domestically focussed mid-cap index tanked 4.1%,
its biggest one-day drop since June 2016 and a fifth straight
day in the red. It also traded more than 10% lower from its
recent peak on Feb. 20 during the session.

Britain's hardline stance on trade talks with the European
Union heaped pressure on domestic equities already battered by
concerns over the virus.

"The sharp declines in equity markets in the last week have
turned investor sentiment on its head in a fashion that is
almost schizophrenic in nature," CMC Markets analyst Michael
Hewson said.

Investors grew increasingly worried about the impact of the
virus outbreak on global supply chains, and Standard Chartered
joined the likes of Apple and Microsoft in
warning of a hit from the epidemic.

The Asia-focussed bank fell 3.6% after saying that
a key earnings target would take longer to meet as the epidemic
added to headwinds in China and Hong Kong.

Rival HSBC slipped 4.6% as the stock also traded
ex-dividend.

Sectors most exposed to China for revenue were battered,
with autos and miners losing 4.2% and
4.8%, respectively.

Both the FTSE 100 and the FTSE 250 are currently on course
for their biggest weekly drop since August 2011. European
markets and Wall Street also slid into correction territory.

"This is one of the worst weeks in recent memory - and
terrifyingly, it's not over yet," Spreadex analyst Connor
Campbell remarked.

He also speculated on future near-term moves in equities,
pondering over whether the recent trend of buying the dips would
entice dealers or if stocks would be stuck in a rut after
Thursday's carnage.

"One way or the other, it's hard to see any tangible good
news appearing to generate a sustainable rebound," he said.

Economic data for January had been fairly upbeat, but
analysts have since sharply cut their forecasts for economic
growth in China and the world, with BofA the most recent to
sound an alarm.

News-driven moves saw ad firm WPP skid almost 16%,
its biggest one-day loss in more than a quarter of a century,
after a disappointing fourth quarter.

Housebuilders endured their worst day in more
than two years, dragged by a 6.6% drop in Persimmon
after it reported lower annual profit and said its Chief
Executive would step down.

But drugmaker Hikma outperformed, adding 4.4% after
it forecast sales growth in 2020.
(Additional reporting by Tom Westbrook in Singapore; Editing by
Bernard Orr and Giles Elgood)

More News
3 Jan 2023 09:25

Hikma launches version of Xyrem medicine in US for treating narcolepsy

(Alliance News) - Hikma Pharmaceuticals PLC on Tuesday said it launched an authorised generic version of the Xyrem sodium oxybate prescription medicine in the US for treating narcolepsy.

Read more
3 Jan 2023 09:24

LONDON BROKER RATINGS: Citigroup cuts Wizz Air; Redburn likes CRH

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning, Monday and late Friday:

Read more
3 Jan 2023 09:03

LONDON MARKET OPEN: Stocks jump in first session of 2023

(Alliance News) - Stock prices in London made a strong start to the new year on Tuesday, despite weak Chinese data and the UK suffering a fresh wave of rail strikes.

Read more
3 Jan 2023 07:58

LONDON BRIEFING: Stocks called higher; China factory sector shrinks

(Alliance News) - Stocks in London are expected to start a new year on the front foot on Tuesday, after a mixed session in Asia amid weak Chinese economic data.

Read more
3 Jan 2023 07:46

Hikma launches generic narcolepsy solution in US

(Sharecast News) - Hikma Pharmaceuticals has launched an authorised generic version of Jazz Pharmaceuticals' 'Xyrem 1', or sodium oxybate oral solution, it announced on Tuesday.

Read more
8 Dec 2022 09:48

LONDON BROKER RATINGS: JPMorgan cuts Travis Perkins; BofA likes IAG

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning:

Read more
6 Dec 2022 10:48

RBC Capital Markets starts Hikma at 'outperform'

(Sharecast News) - RBC Capital Markets initiated coverage of Hikma Pharmaceuticals on Tuesday at 'outperform' with a 1,750p price target.

Read more
6 Dec 2022 10:26

LONDON BROKER RATINGS: JPMorgan cuts Lloyds but raises Barclays

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning:

Read more
15 Nov 2022 12:10

Credit Suisse initiates coverage of Hikma at 'outperform'

(Sharecast News) - Credit Suisse has initiated coverage of Hikma Pharmaceuticals with an 'outperform' rating.

Read more
15 Nov 2022 09:58

LONDON BROKER RATINGS: Jefferies cuts Aston Martin to 'underperform'

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Monday:

Read more
14 Nov 2022 09:25

LONDON BROKER RATINGS: Credit Suisse cuts Ferrexpo to 'neutral'

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

Read more
8 Nov 2022 09:39

LONDON BROKER RATINGS: Peel cuts Persimmon; Liberum raises Hammerson

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Monday:

Read more
3 Nov 2022 11:17

Hikma Pharmaceuticals reiterates 2022 guidance as costs widen

(Alliance News) - Hikma Pharmaceuticals PLC on Thursday reiterated annual guidance for all three of its businesses, continuing to expect them to underperform against 2021 due to rising costs.

Read more
3 Nov 2022 11:08

With tighter purse strings, is parity less probable for the pound?

STOXX 600 down 1.1%

*

Read more
3 Nov 2022 09:28

Banks, insurance dodge carnage as real estate stocks sink

Welcome to the home for real-time coverage of markets brought to you by Reuters reporters. You can share your thoughts with us at .

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.